84 results
Page 3 of 5
S-3ASR
udjzwcj
8 Apr 21
Automatic shelf registration
4:11pm
8-K
EX-10.1
mkqyep famcsi
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
8-K
EX-99.1
fswmr320 6nmo4er
9 Jul 20
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
7:03am
10-Q
7fm0qub5 6wco
7 May 20
Quarterly report
4:03pm
DEF 14A
hbm1u51
29 Apr 20
Definitive proxy
4:02pm
PRE 14A
x6y6xfft cjx7dkw8
14 Apr 20
Preliminary proxy
4:46pm
POSASR
EX-1.2
8cs9 jadqbma
28 Feb 20
Automatic shelf registration (post-effective amendment)
12:00am
10-K
bu1eiqyno2fqae f9r
27 Feb 20
Annual report
4:02pm
F-3ASR
EX-4.5
bxa02dzs2vxk0 k5ii9
1 Nov 19
Automatic shelf registration (foreign)
4:08pm
F-3ASR
EX-4.3
yj9uvo
1 Nov 19
Automatic shelf registration (foreign)
4:08pm
6-K
EX-99.2
c2d 1y5hw1i
6 Jun 19
Orchard Therapeutics Launches Proposed Public Offering
4:31pm
6-K
EX-99.1
ajy4wyj
6 Jun 19
Orchard Therapeutics Launches Proposed Public Offering
4:31pm
F-1
EX-1.1
cz3lc8 jwg3y
3 Jun 19
Registration statement (foreign)
4:33pm
6-K
EX-99.1
782lif
28 May 19
Current report (foreign)
7:23am
20-F/A
EX-4.12
ufv0boey
26 Apr 19
Annual report (foreign) (amended)
4:54pm